Literature DB >> 8131212

Early activation and cell trafficking induced by staphylococcal enterotoxin B: effects of high- versus low-dose challenge on induction of anergy.

S J Bell1, S M Vroegop, S E Buxser.   

Abstract

The in vivo challenge with exogenous superantigen, staphylococcal enterotoxin B (SEB), selectively induces vigorous polyclonal proliferation of T cells bearing the V beta 8+ TcR domain, whereafter the responsive cells become anergic. We used kinetic analyses to compare the effects of primary (1 degree) and secondary (2 degrees) challenge with a high and a low dose of SEB and the conventional antigen, sperm whale myoglobin, to determine the differential effects of in vivo challenge with a superantigen compared with a conventional antigen. We demonstrate that SEB induces very early activation-associated intralymphatic proliferation and trafficking of more T cells than can be accounted for by V beta 8+ T cells alone. Overall, this study indicates that challenge with SEB causes an apparent loss of CD4+ T-helper cell function and provides an essential foundation for the understanding of the mechanisms of peripheral tolerance induction and T cell "memory."

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131212     DOI: 10.1006/cimm.1994.1090

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  The bacterial superantigen Staphylococcal enterotoxin B stimulates lymphocyte locomotor capacity during culture in vitro.

Authors:  I Newman; P C Wilkinson
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

2.  Staphylococcal enterotoxin B primes cytokine secretion and lytic activity in response to native bacterial antigens.

Authors:  K M Mason; T D Dryden; N J Bigley; P S Fink
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

3.  Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies.

Authors:  Daniel Verreault; Jane Ennis; Kevin Whaley; Stephanie Z Killeen; Hatice Karauzum; M Javad Aman; Rick Holtsberg; Lara Doyle-Meyers; Peter J Didier; Larry Zeitlin; Chad J Roy
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.